Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

PCOS Biomarkers from Multiomics Analysis May Improve Diagnosis

Multiomics biomarker research may refine PCOS diagnosis, risk stratification, and monitoring by linking omics signals to endocrine and metabolic disease pathways.

By Dr. A. Nikhil Krishnan, MBBS · Oct 30, 2026 · 5 min read

Endocrinology·Nature

LLM Diabetes Remission Responses Vary by Prompt and Model

A cross-sectional study found large language model responses on type 2 diabetes remission traded off readability, empathy, accuracy,…

Oct 29, 2026

Endocrinology·STAT

Testosterone Decline: Mechanisms, Health Risks, and Clinical Responses

A narrative review examines the secular decline in testosterone, its metabolic and reproductive consequences, and lifestyle and environmental…

Oct 29, 2026

Endocrinology·Fierce HC

Counsel Health launches AI-native weight management program with LillyDirect

Counsel Health enters the GLP-1 market with an AI-native weight management program and LillyDirect partnership for physician-led obesity…

Oct 29, 2026

Endocrinology·STAT

Lilly retatrutide outperformed Ozempic in diabetes head-to-head study

Eli Lilly said retatrutide lowered blood sugar and weight more than Ozempic in a large diabetes study, intensifying…

Oct 29, 2026

Endocrinology·JCI

Metformin Preserves Brain Glucose Uptake in Adults With Insulin Resistance

Metformin preserved brain glucose uptake, structure, and connectivity in older adults with insulin resistance while improving systemic sensitivity…

Oct 28, 2026

Endocrinology·ClinicalTrials

Tirzepatide Phase 3 Obesity Trial Tested Weight Loss in Japan

SURMOUNT-J evaluated once-weekly tirzepatide in Japanese adults with obesity, focusing on weight loss and metabolic and liver markers…

Oct 28, 2026

Endocrinology·STAT

Novo Nordisk Loses Bid to Block Eli Lilly Weight Loss Ads

A U.S. judge rejected Novo Nordisk’s bid to stop Eli Lilly’s weight loss drug ads, deepening a dispute…

Oct 27, 2026

Endocrinology·Ann Intern Med

Depressive and anxiety symptoms in type 1 diabetes: abstract text unavailable

The scraped record includes only the title, so no methods, results, or cohort details are available for a…

Oct 27, 2026

Endocrinology·Becker H

Federal peptides plan may expand compounded access with new safeguards

The White House is reviewing a plan to broaden access to compounded peptides while adding more patient protections…

Oct 27, 2026

Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.